Medically-supervised hormone therapy remains the best way to boost levels of bioavailable growth hormone3. The impact of somatropin (Nutropin AQ) on visceral adipose tissue is evaluated in an open-label trial of Grownup patients with each childhood-onset and Grownup-onset GH deficiency. Doses of somatropin of around 0.012 mg/kg on a daily basis in